Infusion Pump Market Size, Patient Volume, Treatment Adoption Rates, Pricing Analysis, Regulatory Landscape, Clinical Trial Trends, Market Share, and Demand Forecast

Revenue, 2025

USD 17.49 Bn

Forecast Year, 2035

USD 36.42 Bn

CAGR, 2026 - 2035

7.61%

Report Coverage

Global

What is the Infusion Pump Market Size?

The global infusion pump market size is accounted at USD 17.49 billion in 2025 and predicted to increase from USD 18.84 billion in 2026 to approximately USD 36.42 billion by 2035, representing a CAGR of 7.61% from 2026 to 2035. The demand for infusion pumps is being driven by the demand to securely and precisely administer complicated medications, fluids, and nutrients into a patient's body. This demand is quickly increasing because of the growing importance of chronic conditions that need current therapy, the move towards home-based care, and technological developments.

Infusion Pump Market Key Takeaways

• North America region reached a market share of over 38% in 2025.
• By type, the insulin pump fragment segment has held the largest market share in 2025.
• By application, the diabetes management segment captured the biggest revenue share in 2025.
• The hospital segment has registered the highest market share of over 49% in 2025.

Market Overview

Pumps of different kinds convey supplements or prescription to patients, for example, insulin or different chemicals, anti-microbials, chemotherapy medications, and pain killers. These gadgets have various benefits over manual liquid organization, including the capacity to convey liquids in tiny volumes at unequivocally modified rates or at computerized stretches. Undiscovered developing business sectors like India and China, as well as the developing reception of specialty imbuement pumps, give critical learning experiences to implantation pump market players. Nonetheless, the rising rate of medicine blunders and the absence of remote availability in many emergency clinics will present huge difficulties to the market's development during the figure time frame.

Infusion Pump Market Growth Factors

Demand for Pumps in Coronavirus Infection Disease Management to Improve Business Prospects Because of the effect of the COVID-19 pandemic and the vulnerability encompassing its term, the business has seen a huge expansion in its development rate. This is fundamentally because of an expansion in COVID-19 testing in 2020. In any case, there was a lessening underway because of the COVID-19 pandemic because of an absence of laborers and production network disturbances. During the COVID-19 pandemic, for instance, Baxter International saw critical and capriciousness in the interest for specific medical care items. In any case, new item dispatches have supported income development in 2020. For instance, in Jan 2020, Medtronic Ireland sent off Efficio, which is connected to the SynchroMed II intrathecal drug conveyance framework.

The rising commonness of constant illnesses, joined with the increasing expense of medical clinic based implantation treatments, has powered expanded innovative work endeavors to make locally situated mixture items. For instance, the developing patient populace in diabetes, disease, and neurological issues has brought about an expansion popular for long haul care, ideally at home. Moreover, the developing geriatric populace needing long haul care treatments is driving the advancement of new items focused on locally established mixture treatments. The market's top players are zeroing in on specialty medication site of care the board. Ivenix, Inc. fostered the Epic savvy implantation pump in August 2020 to assist patients with staying away from imbuement related wounds.

Infusion Pump Market Outlook

• Industry Growth Overview: The market growth is primarily driven by the increasing prevalence of chronic diseases, a rising geriatric population, and significant technological advancements.
• Global Expansion: The market is expanding robustly, driven by rising chronic diseases, aging populations needing precise drug delivery, and technological innovation like smart pumps with IoT/AI for better safety and EHR integration.
• Major investors: The major companies and key investors in the infusion pump market include leading medical device manufacturers such as Becton, Dickinson and Company (BD), Baxter International, and Medtronic plc., among others.
• Startup Ecosystem: The market's startup ecosystem is focused on technological innovation, particularly leveraging AI, IoT, and wireless connectivity to enhance safety, precision, and remote monitoring of drug delivery.

Major Trends in the Infusion Pump Market

• The increasing use of smart and connected pumps is due in large part to improved clinical safety, real-time monitoring, and EHR interoperability. As many healthcare providers utilize IoT, wireless connectivity, and electronic drug infusion libraries, they are adopting solutions for integrating these technologies into infusion pumps.
• The demand for outpatient and home-based treatment models has led to the development of lightweight, wearable, and portable infusion pumps that are especially suitable for chronic disease patients (e.g., diabetes) and those undergoing long-term treatments.
• With the increasing focus on patient-centric and personalized therapeutic solutions, the number of customizable dosing solutions has grown significantly. Increased emphasis on precision medicine is leading to an increase in diabetes and oncology infusion systems.

Trade Analysis

• As per the worldwide infusion pump import data, between July 2024 and June 2025, the buyers have globally imported 903 shipments of an Infusion pump.
• Such shipments were being assisted by 903 exporters and bought by 1,123 official worldwide buyers.
• Mexico, the United States, and Turkey have come up as the leading three infusion pump importing countries.
• China, Costa Rica, and Germany are the leading 3 exporting countries.

(Source: https://www.volza.com)

• China has shipped 5,549 shipments, followed by Costa Rica with 3,891 shipments and Germany with 2,323, which are the biggest worldwide infusion pump exporters.

(Source: https://www.volza.com)

Market Scope

Infusion Pump Market Regional Insights

North America Dominated Margest Infusion Pump Market

The North America region accounted largest market share in 2025. The district's market is recognized by higher diabetes conclusion and treatment rates, as well as boundless utilization of mobile pumps and ideal repayment arrangements. Clinical gadget mechanical headways in North America are supporting the district's development.

The market in Latin America, the Middle East, and Africa is still in its earliest stages. Notwithstanding, the rising focal point of driving players on growing their presence in these locales will support the market in these areas. China, Japan, and India are instances of arising economies with advanced medical care foundation and offices. Characteristics, for example, high illness trouble, huge government changes, reception of new innovation, and low treatment costs are preparing for market development.

U.S. Infusion Pump Market Size and Growth 2026 to 2035

The U.S. market is experiencing steady growth driven by the rising prevalence of chronic diseases, an aging population, and increasing demand for accurate and controlled drug delivery. Hospitals and home healthcare settings are adopting advanced infusion pumps to improve patient safety, treatment efficiency, and workflow automation. Technological advancements such as smart pumps with dose error reduction systems, wireless connectivity, and integration with electronic health records are reshaping the market.

The U.S. infusion pump market size is estimated at USD 5.05 billion in 2025 and is predicted to be worth around USD 9.93 billion by 2035, at a CAGR of 7.81% from 2026 to 2035.

In the Asia Pacific, China led the market due to growing demand for home healthcare and convenient precision drug delivery options. Moreover, the country's massive aging population and surge in chronic conditions need precise and long-term infusion therapies, boosting product demand.

China Infusion Pump Market Trends

China's market is expanding rapidly, driven by increasing demand for advanced drug delivery systems in hospitals, outpatient care, and home healthcare settings. Growth is fueled by the rising prevalence of chronic diseases, an aging population, and government initiatives to improve healthcare accessibility and quality.

The growth of the market in the country can be fuelled by the country's strong healthcare system and heavy spending on technology. Moreover, the presence of major market players and research institutions drives advancements and early adoption of infusion pumps in the country.

Europe had the second biggest piece of the pie. An expansion in the commonness of persistent sicknesses around here, as well as huge consumption in the medical services area by the European Commission, are supposed to drive interest for these pumps in Europe somewhere in the range of 2026 and 2035.

The market in rising locales like Latin America, Asia Pacific, the Middle East and Africa is supposed to develop at a quicker rate during the conjecture time frame. Ascend in the predominance of persistent illnesses like diabetes and disease, developing medical care framework, developing GDP, extra cash, and expanding mindfulness about the accessibility of cutting-edge treatments in the Asia Pacific district are a portion of the variables expected to drive market development around here before long. The Asia Pacific market is supposed to develop at an 8.8% compound annual growth rate during the gauge time frame.

Germany Infusion Pump Market Trends

The German market is growing steadily, driven by rising demand for precise and safe drug delivery in hospitals, clinics, and home healthcare settings. An aging population and increasing prevalence of chronic diseases such as diabetes and cancer are fueling the adoption of both smart and ambulatory infusion pumps. Technological innovations, including wireless connectivity, integration with electronic health records, and dose-error reduction systems, are enhancing safety, efficiency, and clinical workflow.

Government Initiatives taken for Infusion Pump Market

• In August 2025, Terumo India, which is a subsidiary of Japan-based Terumo Corporation, disclosed its Terufusion Advanced Infusion Systems in India, which links infusion technology to assist secure and more effective drug administration in intensive care units (ICUs). (Source: https://ehealth.eletsonline.com)

Partnership Landscape

• In February 2026, Fresenius Kabi and Phlow Corphas recently disclosed their initial collaboration to onshore the production of an Epinephrine Injection, USP, which is a necessary medicine long at risk of chronic shortage in the United States and is widely used in hospitals globally. (Source: https://www.fresenius-kabi.com)
• In April 2026, Fortis Hospital Manesar revealed Fortis Cancer Institute, which is the first focused cancer institute in Manesar, marking a major leap in technology- and accuracy-led cancer care. (Source: https://thewire.in/ptiprnews)

Infusion Pump Market Value Chain Analysis

• Research & Development: This involves designing advanced, safe, and interoperable smart pumps with features like wireless connectivity and safety software.
• Manufacturing and Assembly: This stage involves the physical production of the devices and associated consumables.
• Distribution and Sales: This stage focuses on getting the products to the end-users. Products are distributed through direct sales forces and third-party distributors.
• End-User Application: The final stage involves the actual use of the pumps and subsequent support. The primary end-users are hospitals, followed by home care settings and oncology centers.

Infusion Pump Market Companies

• Becton, Dickinson and Company (BD): Offers the widely recognized BD Alaris™ infusion system, a modular platform that includes large-volume, syringe, and patient-controlled analgesia (PCA) pumps.
• Baxter International: Provides a broad spectrum of infusion systems and devices, sterile IV solutions, and associated software innovations.
• Tandem Diabetes Care, Inc.
• Smith Medical
• Terumo Corporation
• Becton, Dickinson and Company
• Fresenius SE & Co. KGaA
• F. Hoffmann-La Roche Ltd.
• B. Braun Holding GmbH & Co. KG
• Baxter International, Inc.
• Medtronic
• ICU Medical, Inc.

Recent Developments

• Mindray has presented the BeneFusion n Series, another age imbuement framework. It gives profound experiences into patient security, interoperability and information the board, and functional effortlessness, all of which add to the foundation of new guidelines in mixture treatment.
• Teknor Apex Co., a plastics intensifying organization, presented new, profoundly weatherable mixtures for the external layers of dim shaded wood plastic composite (WPC) decking in February 2021. WPC decking is produced using a blend of wood flour and polyolefin plastics and is turning out to be progressively well known as an option in contrast to customary treated wood. The new mixtures might give a huge benefit to WPC over wood by giving a prevalent appearance, lower upkeep prerequisites, and a more extended life expectancy.
• AZEk, a composite board producer, declared in March 2021 the development of another plant in Boise, Idaho, to extend its creation of composite wood utilizing reused PE. As per the Chicago-based producer, retrofitting and development of the office will start before the current year's over, with the plant expected to be functional in 2022. AZEK plans to produce its TimberTech image blunder, produced using recuperated PE and wood, at the Boise production line, which is essential for a US$180 million limit development program.

Market Segmentation

By Product

• Accessories and Consumables
  • Dedicated Accessories and Consumables
    • Volumetric Infusion Pumps
    • Insulin Pumps
    • Enteral Infusion Pumps
    • Syringe Infusion Pumps
    • Ambulatory Infusion Pumps
    • PCA Pumps
    • Implantable Infusion Pumps
  • Non- Dedicated Accessories and Consumables
    • Infusion Catheters
    • IV/administration Sets
    • Needleless Connectors
    • Cannulas
    • Tubing & Extension Sets
    • Valves
    • Other Non-Dedicated Accessories and Consumables
• Devices
  • By Product
    • Volumetric Infusion Pumps
    • Insulin Pumps
    • Enteral Infusion Pumps
    • Syringe Infusion Pumps
    • Ambulatory Infusion Pumps
    • PCA Pumps
    • Implantable Infusion Pumps
  • By Technology
    • Traditional Infusion Pumps
    • Specialty Infusion Pumps
  • By Type
    • Stationary Infusion Pumps
    • Portable Infusion Pumps

By Application

• Chemotherapy/Oncology
• Diabetes Management
• Gastroenterology
• Pain Management/ Analgesia
• Pediatrics/ Neonatology
• Hematology
• Other Applications

By End User

• Hospitals
• Home Care Settings
• Ambulatory Care Settings
• Academic and Research Institutes

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa